Patterns of adjuvant treatment and survival outcomes in stage I uterine carcinosarcoma

Lori Cory, Colleen Brensinger,Robert A Burger,Robert L Giuntoli,Mark A Morgan,Nawar Latif,Lilie L Lin,Emily M Ko

Gynecologic Oncology Reports（2022）

引用 0|浏览15

暂无评分

摘要

•5-year survival for stage I uterine carcinosarcoma without adjuvant therapy is 43%.•Nationally 40% of stage I uterine carcinosarcoma do not receive adjuvant therapy.•Adjuvant chemotherapy alone improved OS and CSS in stage I uterine carcinosarcoma.

查看译文

关键词

Uterine carcinosarcoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要